Skip to main content
Premium Trial:

Request an Annual Quote

Altona Diagnostics Hepatitis C Virus Kit Gets CE-IVD Mark

NEW YORK (GenomeWeb) – Altona Diagnostics said today that it has received CE-IVD marking for and has launched the AltoStar HCV RT-PCR Kit 1.5.

The kit leverages real-time RT-PCR technology to detect and quantify hepatitis C virus-specific RNA with genotypes 1 to 6. The Hamburg, Germany-based company said that the assay is its first List A test, in compliance with the In vitro Diagnostic Directive 98/79/EC.

The assay, which received CE-IVD designation on Wednesday, was developed to be used with Altona's AltoStar Automation System AM16, the AltoStar Purification Kit 1.5, the AltoStar Internal Control 1.5, and Bio-Rad Laboratories' CFX96 Deep Well Real-Time PCR Detection system.

Altona added that additional AltoStar products would soon be available, including tests for hepatitis E virus, hepatitis B virus, and alpha herpesviruses.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.